StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Litigation accrual reserve by Quarter

Litigation accrual reserve (Antitrust, patent & product liability, $M) ($M)

Gilead Sciences Litigation accrual reserve: $0M in Q2 2026. That is the lowest of the 15 quarters on record here.

Latest, Q2 2026
0
Period ended Jun 30, 2026
Change on a year earlier
–
0 in Q2 2025
History
15 quarters
Since Q4 2021
Sources
14
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-06) ↗

Reported in Form 10-Q / 10-K Note 12 Commitments and Contingencies.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLitigation accrual reserve (Antitrust, patent & product liability, $M) ($M)Year on yearSource
Q2 2026Jun 30, 20260–Form 10-Q (filed 2026-08-06) ↗
Q1 2026Mar 31, 20260-100.0%Form 10-Q (filed 2026-05-07) ↗
Q4 2025Dec 31, 20250-100.0%Form 10-Q (filed 2026-08-06) ↗
Q3 2025Sep 30, 20250–Form 10-Q (filed 2025-11-07) ↗
Q2 2025Jun 30, 20250–Form 10-Q (filed 2025-08-07) ↗
Q1 2025Mar 31, 2025220–Form 10-Q (filed 2025-05-07) ↗
Q4 2024Dec 31, 2024242–Form 10-K (filed 2026-02-24) ↗
Q4 2023Dec 31, 20230–Form 10-K (filed 2025-02-28) ↗
Q3 2023Sep 30, 20230–Form 10-Q (filed 2023-11-07) ↗
Q2 2023Jun 30, 20230–Form 10-Q (filed 2023-08-04) ↗
Q4 2022Dec 31, 20220-100.0%Form 10-K (filed 2024-02-23) ↗
Q3 2022Sep 30, 20220–Form 10-Q (filed 2022-11-02) ↗
Q2 2022Jun 30, 20220–Form 10-Q (filed 2022-08-08) ↗
Q1 2022Mar 31, 20220–Form 10-Q (filed 2022-05-04) ↗
Q4 2021Dec 31, 20211,250–Form 10-K (filed 2023-02-22) ↗

Breakdown

What makes up litigation accrual reserve

Cite this data

StockData. (2026). Gilead Sciences Litigation accrual reserve ($M), quarterly Q4 2021–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/lit-reserve-tot

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.